Ligand Pharmaceuticals
LGND
LGND
268 hedge funds and large institutions have $2.18B invested in Ligand Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 110 increasing their positions, 84 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
268
Holders Change
+10
Holders Change %
+3.88%
% of All Funds
3.59%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.05%
New
35
Increased
110
Reduced
84
Closed
23
Calls
$1.11M
Puts
$11K
Net Calls
+$1.1M
Net Calls Change
+$964K
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$38.2M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$12.5M |
| 3 |
PCMF
Private Capital Management (Florida)
Naples,
Florida
|
+$9.22M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$7.04M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.76M |
Top Sellers
| 1 |
CM
Castleark Management
Chicago,
Illinois
|
-$6.99M |
| 2 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
-$6.23M |
| 3 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$5.04M |
| 4 |
LCG
Lisanti Capital Growth
New York
|
-$4.76M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.59M |
